Stay updated on Cabozantib in RET+ NSCLC: Phase II Clinical Trial

Sign up to get notified when there's something new on the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page's Revision tag has been updated to v3.6.3, replacing the previous v3.6.2. This indicates a minor maintenance update to the site version tag.
    Difference
    0.0%
    Check dated 2026-07-03T22:03:20.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The revision line on the page was updated from Revision: v3.6.0 to Revision: v3.6.2. This indicates a newer version of the page content.
    Difference
    0.0%
    Check dated 2026-06-27T02:04:37.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Removed sponsor/investigator identifiers and a drug description line, along with the attribution note, diminishing attribution and navigational context on the study's details page.
    Difference
    0.2%
    Check dated 2026-06-19T21:38:45.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The study record text adds investigator-related items and navigation sections (including Andrea Ardizzoni and several help/section labels) and updates the revision to v3.6.0, while removing the previous attribution and the older Intervention / Treatment label.
    Difference
    1%
    Check dated 2026-06-12T14:24:45.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page revision was updated to v3.5.5, indicating a minor maintenance update to the study details page.
    Difference
    0.0%
    Check dated 2026-06-05T10:27:26.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    A CABOSUN trial reference was added to the Publications section, and the previous erratum citation along with its revision tag (v3.5.3) was removed; this represents a bibliographic update to sources cited on the page.
    Difference
    0.1%
    Check dated 2026-05-14T23:01:27.000Z thumbnail image

Stay in the know with updates to Cabozantib in RET+ NSCLC: Phase II Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page.